News Agency
Men's Weekly

Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting

  • Written by PR Newswire

BEIJING, SHANGHAI, and SAN DIEGO, April 9, 2024 /PRNewswire/ -- Jacobin Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that the company will present the results of two preclinical evaluation of PARP7 inhibitor JAB-26766 and p53 Y220C reactivator JAB-30355 in form of the abstract during the...

Read more: Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual...

Aligning Social, Email, and Web Campaigns with Structured Content: Building a Unified Marketing Engine

Few modern marketing campaigns exist in a bubble. A product launch, for example, may kick off with social media buzz, continue into a targeted email campaign, and finish with a conversion-focused web experience. Ideally, all three touchpoints communicate the same... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion